Market Intelligence Ecosystem
Alkem Laboratories Ltd (NSE:ALKEM) Q4 FY23 Earnings Concall dated May. 19, 2023. Corporate Participants: Amit Khandelia -- Associate Vice President, Finance Sandeep Singh -- Managing Director
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked if backward
Dishman Carbogen Amcis Limited is a global pharmaceutical contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of
Chemcrux Enterprises Limited, incorporated in April 1996, is a company engaged in the manufacturing of bulk drug intermediates. Their product range includes
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is
Gland Pharma Limited (NSE:GLAND) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Sumanta Bajpayee -- Vice President, Finance and Investor Relations Srinivas
Abbott India Ltd is a prominent multinational pharmaceutical company operating in India. Established in 1944, it has emerged as a key player
Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India. Established in 1977, the company has grown to become a
BDH Industries Ltd. is a manufacturing company that specializes in the production of therapeutic formulations, encompassing a wide range of pharmaceutical products.
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Gland Pharma Limited specializes in the production of sterile injectable formulations, including vials, ampoules, pre-filled syringes, and lyophilized products. The company's focus
GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range
Granules India Ltd (NSE:GRANULES) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Krishna Prasad -- Chairman and Managing Director
Granules India Limited reported Total Income for Q4 FY23 of ₹1,198.87 Crore up from ₹1,033.93 Crore year on year, a growth of
Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active
Themis Medicare Ltd (NSE: THEMISMED) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Patel -- Managing Director and Chief Executive Officer
Gujarat Themis Biosyn Limited (NSE: 506879) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Dinesh Patel -- Director Rajneesh Anand -- Consultant Tushar
Key highlights from Cipla Limited (CIPLA) Q4 FY23 Earnings Concall Management Update: [00:05:08] CIPLA said its U.S. business crossed $200 million in
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q4 FY23 Earnings Concall dated May. 12, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Jitesh Devendra -- Managing Director
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Cipla Limited reported Total Income for Q4 FY23 of ₹5,873.93 Crore up from ₹5,324.35 Crore year on year, a growth of 10.3%.